Previous reports on
pernicious anemia treatment suggested that high
folic acid intake adversely influences the natural history of
vitamin B-12 deficiency, which affects many elderly individuals. However, experimental investigation of this hypothesis is unethical, and the few existing observational data are inconclusive. With the use of data from the 1999-2002 National Health and Nutrition Examination Survey (NHANES), we evaluated the interaction between high serum
folate and low
vitamin B-12 status [ie, plasma
vitamin B-12 < 148 pmol/L or
methylmalonic acid (MMA) > 210 nmol/L] with respect to
anemia and
cognitive impairment. With subjects having both plasma
folate < or = 59 nmol/L and normal
vitamin B-12 status as the referent category, odds ratios for the prevalence of
anemia compared with normal
hemoglobin concentration and impaired compared with unimpaired cognitive function were 2.1 (95% CI: 1.1, 3.7) and 1.7 (95% CI: 1.01, 2.9), respectively, for those with low
vitamin B-12 status but normal serum
folate and 4.9 (95% CI: 2.3, 10.6) and 5.0 (95% CI: 2.7, 9.5), respectively, for those with low
vitamin B-12 status and plasma
folate >59 nmol/L. Among subjects with low
vitamin B-12 status, mean circulating
vitamin B-12 was 228 pmol/L for the normal-
folate subgroup and 354 pmol/L for the high-
folate subgroup. We subsequently showed increases in circulating
homocysteine and MMA concentrations with increasing serum
folate among NHANES participants with serum
vitamin B-12 < 148 pmol/L, whereas the opposite trends occurred among subjects with serum
vitamin B-12 > or = 148 pmol/L. These interactions, which were not seen in NHANES III before fortification, imply that, in
vitamin B-12 deficiency, high
folate status is associated with impaired activity of the 2
vitamin B-12-dependent
enzymes,
methionine synthase and MMA-
coenzyme A mutase.